Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-269984A is an antagonist of Prostaglandin E2 Receptor 1 (EP1) (pIC50: 7.9).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | GSK-269984A is an antagonist of Prostaglandin E2 Receptor 1 (EP1) (pIC50: 7.9). |
Targets&IC50 | EP1 receptor:7.9 (pic50) |
In vitro | GSK-269984A is found to cause a concentration-dependent rightward shift of the PGE2 dose-response curve and Schild analysis displays that GSK-269984A is a competitive antagonist with pA2 8.1±0.3 and slope 1.0[1]. |
In vivo | GSK-269984A(10 mg/kg,p.o.) treatment, showing equivalent reversal of hypersensitivity to the standard(ED50: 2.6 mg/kg). GSK-269984A displays moderate blood clearance in the rat and dog and high clearance in the monkey which is reflected in the half-life for each species[1]. |
Molecular Weight | 429.22 |
Formula | C20H14Cl2FNNaO3 |
CAS No. | 892664-04-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-269984A 892664-04-9 Others GSK269984A GSK 269984A inhibitor inhibit